Laura Santana Viera

Dr. Laura Santana Viera

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2020 in Cancers
Verified
Journal Article
Open access
PDF file
LVLaura Santana Viera
Laura Santana Viera
MIMaria Luigia Ibba
Maria Luigia Ibba
Deborah RotoliDeborah Rotoli
Deborah Rotoli
Silvia CatuognoSilvia Catuogno
Silvia Catuogno
CECarla Lucia Esposito
Carla Lucia Esposito
Tumor mass consists of a complex ensemble of malignant cancer cells and a wide variety of resident and infiltrating cells, secreted factors, and extracellular matrix proteins that are referred as tumor microenvironment (TME). Cancer associated fibroblasts (CAFs) are key TME components that support tumor growth, generating a physical barrier against drugs and immune infiltration, and contributing to regulate malignant progression. Thus, it is largely accepted that therapeutic approaches aimed at hampering the interactions between tumor cells and CAFs can enhance the effectiveness of anti-cancer treatments. In this view, nucleic acid therapeutics have emerged as promising molecules. Here, we summarize recent knowledge about their role in the regulation of CAF transformation and tumor-promoting functions, highlighting their therapeutic utility and challenges.

25 December 2025 in bioRxiv
Verified
Preprint
Open access
SSSara Sanchez-Serra
Sara Sanchez-Serra
MCMariona Chicon-Bosch
Mariona Chicon-Bosch
NMNuria Martorell-Villanueva
Nuria Martorell-Villanueva
ECEduardo Candeal
Eduardo Candeal
IJIgnasi Jarne-Sanz
Ignasi Jarne-Sanz
OTOscar M Tirado
Oscar M Tirado
Metastatic Ewing sarcoma (EwS) remains a major clinical challenge, highlighting the need to identify molecular drivers of disease dissemination. Through integrated transcriptomic, functional, and mechanistic analyses, we identify PARP14 as a key regulator of EwS metastatic progression. PARP14 is consistently upregulated in metastatic lesions across spontaneous and xenograft mouse models as well as in patient samples. Genetic and pharmacologic depletion of PARP14 (via siRNA knockdown, CRISPR-Cas9 knockout, or PROTAC-mediated degradation) significantly impaired EwS cell migration and invasion in vitro, without affecting proliferation or clonogenic capacity. In vivo, PARP14 loss delayed tumor growth and reduced metastatic burden, supporting a functional role in disease progression. Conversely, IFNγ-induced PARP14 upregulation and stable overexpression enhanced EwS cell migration and increased lung metastasis formation. Transcriptomic profiling of PARP14-deficient cells revealed downregulation of invasive signatures and enrichment of inflammatory and p53-related pathways, together with gene sets associated with chromatin remodeling. Subcellular fractionation and interactome analyses showed that PARP14 localizes to cytoplasmic, nuclear, and chromatin-associated compartments, and interacts with chromatin, cytoskeletal and ECM regulators. ChIP analyses further demonstrated PARP14 binding to promoters enriched for NRF1 motifs, suggesting a role as a transcriptional co-regulator influencing gene networks relevant to EwS progression. Together, our results establish PARP14 as a contributor to EwS dissemination and uncover a previously unappreciated chromatin-associated role for this protein, supporting its potential as both a biomarker and therapeutic target in metastatic EwS.

15 March 2016 in Desalination and Water Treatment
Verified
Journal Article
Open access
EElisenda Pulido-Melián
Elisenda Pulido-Melián
LVLaura Santana Viera
Laura Santana Viera
EOE. Otal
E. Otal
José M. Doña-RodríguezJosé M. Doña-Rodríguez
José M. Doña-Rodríguez
DSDunia E. Santiago
Dunia E. Santiago
LVL.F. Vilches
L.F. Vilches
The aim of this study was to find a recycling use for waste material (WTiO2) that results from the extraction process of TiO2 from ilmenite in the pigment industry. In view of its high TiO2 content, the photocatalytic activity of this material was tested in the degradation of humic and fulvic acid substances (HFAs) and showed low levels of photoactivity, as was the case for the commercial photocatalyst Aeroxide TiO2 P25 (P25). However, due to its high Fe3+ content, an important application was observed for WTiO2 as an HFA coagulant and catalyst in Fenton and photo-Fenton processes. A two-stage process of coagulation and photo-Fenton treatment was subsequently designed and conducted at laboratory and small pilot scale. High percentages (above 95%) were obtained in total organic carbon (TOC) removal.